Yuichi Hayashi
Overview
Explore the profile of Yuichi Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakurai K, Tokumaru A, Yoshida M, Saito Y, Wakabayashi K, Komori T, et al.
Neuroradiology
. 2024 Jul;
66(11):1917-1929.
PMID: 39039147
Purpose: Due to the indistinguishable clinical features of corticobasal syndrome (CBS), the antemortem differentiation between corticobasal degeneration (CBD) and its mimics remains challenging. However, the utility of conventional magnetic resonance...
2.
Kunieda K, Hayashi Y, Fujishima I, Shimohata T
Intern Med
. 2024 May;
64(1):133-136.
PMID: 38749729
Nutritional interventions targeting weight loss are useful for the treatment of amyotrophic lateral sclerosis (ALS). However, the changes in body composition after nutritional intervention remain unclear. We herein present a...
3.
Denda Y, Matsuo Y, Nonoyama K, Murase H, Kato T, Hayashi Y, et al.
Mol Clin Oncol
. 2024 Jan;
20(1):2.
PMID: 38223405
The frequency of metastasis to the pancreas is limited, and the frequency of metastasis of a squamous cell carcinoma of the esophagus is limited even further. The curative resection of...
4.
Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, et al.
Brain Commun
. 2023 Dec;
5(6):fcad296.
PMID: 38090279
The clinical presentation of corticobasal degeneration is diverse, while the background pathology of corticobasal syndrome is also heterogeneous. Therefore, predicting the pathological background of corticobasal syndrome is extremely difficult. Herein,...
5.
Sakurai S, Maezawa M, Nakao S, Hirofuji S, Miyasaka K, Yamashita M, et al.
J Neurol Sci
. 2023 Nov;
455:122789.
PMID: 37984106
Background: Progressive multifocal leukoencephalopathy (PML) has been reported as the development of drugs with immunomodulatory properties, such as anticancer, immunosuppressive, and biological agents, has accelerated. To clarify an incidence profile...
6.
Hayashi Y, Hyodo F, Tana , Nakagawa K, Ishihara T, Matsuo M, et al.
Heliyon
. 2023 Aug;
9(8):e18401.
PMID: 37533986
Depression in later life is associated with dementia. Changes in motivated behavior are an important mechanism contributing to dysfunctional cognitive control in depression. Although continuous intake of quercetin-rich onion suppresses...
7.
Hayashi Y, Matsuo Y, Denda Y, Nonoyama K, Murase H, Ueda G, et al.
Oncol Rep
. 2023 Jul;
50(3).
PMID: 37503752
Girdin, an actin‑binding protein, is reportedly involved in the invasion and angiogenesis of various cancers. It has been suggested that the flavonoid Scutellarin (SCU) inhibits Girdin signaling. In the present...
8.
Murase H, Matsuo Y, Denda Y, Nonoyama K, Kato T, Aoyama Y, et al.
Oncol Rep
. 2023 Jul;
50(3).
PMID: 37477162
Pancreatic cancer (PaCa) tends to be resistant to chemotherapy and is associated with a very poor prognosis. It has been previously reported by the authors that integrin‑linked kinase (ILK) is...
9.
Nishida S, Kato T, Hayashi Y, Yamada S, Fujii H, Yamada M, et al.
J Diabetes Investig
. 2023 Jun;
14(10):1202-1208.
PMID: 37357565
Aims/introduction: Polypharmacy in diabetes patients is related to worse clinical outcomes. The aim of this study was to evaluate the usefulness of our countermeasure for polypharmacy, which combines a pharmacist...
10.
Saito T, Matsuo Y, Aoyama Y, Kato T, Omi K, Hayashi Y, et al.
Gan To Kagaku Ryoho
. 2023 Apr;
50(4):520-522.
PMID: 37066474
An-81-year-old man presented to another doctor complaining of epigastric pain. He was referred to us after the laboratory data revealed a high serum CEA and abdominal ultrasonography showed the space...